Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
PUT
Perdoceo Education
PRDO
$2.07B
| $68K | ﹤0.01% |
22,800
+11,100
| +95% | +$46.9K |
|
4852
Toro Company
TTC
$9.42B
| $68K | ﹤0.01% |
2,030
+1,770
| +681% | +$60.7K |
|
4853
Telus
TU
$15.4B
| $68K | ﹤0.01% |
4,000
-564
| -12% | -$9.68K |
|
|
ECYT
4854
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $68K | ﹤0.01% |
13,503
-3,937
| -23% | -$23.6K |
|
|
PDLI
4855
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
| $68K | ﹤0.01% |
11,300
-11,700
| -51% | -$78.4K |
|
4856
PUT
BCE
BCE
$20.6B
| $67K | ﹤0.01% |
1,600
-2,100
| -57% | -$92.2K |
|
4857
CALL
Cabot Corp
CBT
$4.36B
| $67K | ﹤0.01% |
1,800
-200
| -10% | -$8.63K |
|
4858
New York Times
NYT
$10.6B
| $67K | ﹤0.01% |
5,133
-22,488
| -81% | -$310K |
|
4859
PUT
Prologis
PLD
$131B
| $67K | ﹤0.01% |
1,800
+1,500
| +500% | +$61K |
|
4860
CALL
Uranium Energy
UEC
$5.31B
| $67K | ﹤0.01% |
+67,400
| New | +$154K |
|
|
TRQ
4861
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $67K | ﹤0.01% |
2,230
+2,020
| +962% | +$83.1K |
|
|
MWW
4862
PUT
DELISTED
Monster Worldwide Inc
MWW
| $67K | ﹤0.01% |
11,200
+400
| +4% | +$2.49K |
|
|
ALEX
4863
DELISTED
Alexander & Baldwin
ALEX
| $66K | ﹤0.01% |
1,704
-13,078
| -88% | -$538K |
|
4864
Apple Hospitality REIT
APLE
$3.91B
| $66K | ﹤0.01% |
+3,695
| New | +$69.2K |
|
4865
Commault Systems
CVLT
$5.52B
| $66K | ﹤0.01% |
1,595
-660
| -29% | -$29.9K |
|
4866
PUT
Designer Brands
DBI
$339M
| $66K | ﹤0.01% |
2,000
-5,400
| -73% | -$193K |
|
4867
iShares S&P GSCI Commodity-Indexed Trust
GSG
$952M
| $66K | ﹤0.01% |
3,156
| – | – |
|
|
CALY
4868
CALL
Callaway Golf Company
CALY
$3.44B
| $66K | ﹤0.01% |
8,200
-2,300
| -22% | -$22K |
|
4869
Molson Coors Class A
TAP.A
$7.83B
| $66K | ﹤0.01% |
+929
| New | +$75K |
|
4870
Tetra Tech
TTEK
$8.78B
| $66K | ﹤0.01% |
13,155
-75,975
| -85% | -$389K |
|
4871
UMB Financial
UMBF
$11.2B
| $66K | ﹤0.01% |
1,153
-14,730
| -93% | -$792K |
|
|
MTEM
4872
DELISTED
Molecular Templates, Inc.
MTEM
| $66K | ﹤0.01% |
100
+50
| +100% | +$33K |
|
|
AJRD
4873
PUT
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $66K | ﹤0.01% |
3,300
| – | – |
|
|
CHU
4874
PUT
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $66K | ﹤0.01% |
4,400
+1,000
| +29% | +$17.5K |
|
|
CIM
4875
PUT
Chimera Investment
CIM
$991M
| $65K | ﹤0.01% |
+1,667
| New | +$74.4K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.